The sigma receptor agonist SA4503 both attenuates and enhances the effects of methamphetamine

Drug and Alcohol Dependence

Volumn 116, Issue 1-3, 2011, Pages 203-210

  Rodvelt, Kelli R ^a   Oelrichs, Clark E ^a   Blount, Lucas R ^a   Fan, Kuo Hsien ^a   Lever, Susan Z ^a   Lever, John R ^b,c   Miller, Dennis K ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Dopamine release; Drug discrimination; Locomotor activity; Methamphetamine; Sigma receptors

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BD 1063; CUTAMESINE; METHAMPHETAMINE; N [2 (3,4 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; SIGMA OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; HYPERACTIVITY; MALE; NONHUMAN; PERCEPTIVE DISCRIMINATION; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DISCRIMINATION LEARNING; DOPAMINE; DRUG INTERACTIONS; ETHYLENEDIAMINES; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; NEOSTRIATUM; NOOTROPIC AGENTS; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA;

RATTUS;

EID: 79957582735     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.12.018     Document Type: Article

References (29)

1. Eshleman A.J., Carmolli M., Cumbay M., Martens C.R., Neve K.A., Janowsky A. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type. J. Pharmacol. Exp. Ther. 1999, 289(2):877-885.
2. Fujimura K., Matsumoto J., Niwa M., Kobayashi T., Kawashima Y., In Y., Ishida T. Synthesis, structure and quantitative structure-activity relationships of sigma receptor ligands, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl) piperazines. Bioorg. Med. Chem. 1997, 5(8):1675-1683.
3. 3H]dopamine release from rat striatal slices by sigma receptor ligands. J. Pharmacol. Exp. Ther. 1994, 271(1):212-219.
4. Hayashi T., Justinova Z., Hayashi E., Cormaci G., Mori T., Tsai S.Y., Barnes C., Goldberg S.R., Su T.P. Regulation of σ-1 receptors and endoplasmic reticulum chaperones in the brain of methamphetamine self-administering rats. J. Pharmacol. Exp. Ther. 2010, 332(3):1054-1063.
5. Hayashi T., Su T.P. Regulating ankyrin dynamics: roles of sigma-1 receptors. Proc. Natl. Acad. Sci. U.S.A. 2001, 98(2):491-496.
6. 1 receptor agonist, 1-(3,4-dimethoxyphenethyl)-4-(phenylpropyl)piperazine (SA4503), blocks the acquisition of the conditioned place preference response to (-)-nicotine in rats. Eur. J. Pharmacol. 2001, 426(1-2):R1-2.
7. 11C]methylvesamicol as a PET ligand for vesicular acetylcholine transporter. Ann. Nucl. Med. 2006, 20(6):417-424.
8. 2 receptor binding affinity and selectivity of SA4503 and fluoroethyl SA4503. Synapse 2006, 59(6):350-358.
9. Maskos U. Role of endogenous acetylcholine in the control of the dopaminergic system via nicotinic receptors. J. Neurochem. 2010, 114(3):641-646.
10. Matsumoto R.R., Shaikh J., Wilson L.L., Vedam S., Coop A. Attenuation of methamphetamine-induced effects through the antagonism of sigma (σ) receptors: evidence from in vivo and in vitro studies. Eur. Neuropsychopharmacol. 2008, 18(12):871-881.
11. 1 receptor agonist. Eur. J. Pharmacol. 1996, 306(1-3):271-279.
12. Meurs A., Clinckers R., Ebinger G., Michotte Y., Smolders I. Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y. Eur. J. Neurosci. 2007, 26(11):3079-3092.
13. Miller D.K., Crooks P.A., Dwoskin L.P. Lobeline inhibits nicotine-evoked [(3)H]dopamine overflow from rat striatal slices and nicotine-evoked (86)Rb(+) efflux from thalamic synaptosomes. Neuropharmacology 2000, 39(13):2654-2662.
14. Miller D.K., Dopheide M.M., Smith S.M., Casteel S.W. Dietary cadmium exposure attenuates d-amphetamine-evoked [3H]dopamine release from striatal slices and methamphetamine-induced hyperactivity. Pharmacol. Biochem. Behav. 2005, 80(4):557-566.
15. 1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study. Synapse 1999, 33(2):129-140.
16. 1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures. Neurochem. Int. 1998, 32(4):337-343.
17. Nguyen E.C., McCracken K.A., Liu Y., Pouw B., Matsumoto R.R. Involvement of sigma (σ) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies. Neuropharmacology 2005, 49(5):638-645.
18. Patrick S.L., Walker J.M., Perkel J.M., Lockwood M., Patrick R.L. Increases in rat striatal extracellular dopamine and vacuous chewing produced by two σ receptor ligands. Eur. J. Pharmacol. 1993, 231(2):243-249.
19. Peter D., Jimenez J., Liu Y., Kim J., Edwards R.H. The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J. Biol. Chem. 1994, 269(10):7231-7237.
20. Polston J.E., Cunningham C.S., Rodvelt K.R., Miller D.K. Lobeline augments and inhibits cocaine-induced hyperactivity in rats. Life Sci. 2006, 79(10):981-990.
21. Skuza G. Effect of sigma ligands on the cocaine-induced convulsions in mice. Pol. J. Pharmacol. 1999, 51(6):477-483.
22. 1 receptor agonist. Behav. Pharmacol. 2002, 13(7):537-543.
23. 1 receptor upregulation after chronic methamphetamine self-administration in rats: a study with yoked controls. Psychopharmacology (Berl) 2004, 175(1):68-75.
24. 1 receptor. Sci. Signal 2009, 2(61):pe12.
25. Ujike H., Kanzaki A., Okumura K., Akiyama K., Otsuki S. Sigma (σ) antagonist BMY 14802 prevents methamphetamine-induced sensitization. Life Sci. 1992, 50(16):PL129-134.
26. Ujike H., Okumura K., Zushi Y., Akiyama K., Otsuki S. Persistent supersensitivity of sigma receptors develops during repeated methamphetamine treatment. Eur. J. Pharmacol. 1992, 211(3):323-328.
27. Walker J.M., Bowen W.D., Walker F.O., Matsumoto R.R., De Costa B., Rice K.C. Sigma receptors: biology and function. Pharmacol. Rev. 1990, 42(4):355-402.
28. Yamazaki Y., Ishioka M., Matsubayashi H., Amano T., Sasa M. Inhibition by sigma receptor ligand, MS-377, of N-methyl-d-aspartate-induced currents in dopamine neurons of the rat ventral tegmental area. Psychopharmacology (Berl) 2002, 161(1):64-69.
29. 1 receptor agonist SA4503 and neuroactive steroids on performance in a radial arm maze task in rats. Neuropharmacology 2000, 39(9):1617-1627.